Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quantitative Radiology Solutions (QRS) is a medical technology company that provides advanced body-wide quantification of medical images to personalize cancer treatment decisions. Spun out of the University of Pennsylvania's Medical Image Processing Group, the company's flagship product is the Automatic Anatomy Recognition (AAR) system, an FDA 510(k) cleared software-only medical device. AAR automates the localization and delineation of organs-at-risk (OAR) in CT, MRI, and PET/CT images, reducing the time required for radiation treatment planning from hours to minutes. The technology aims to improve the accuracy and consistency of contouring, thereby minimizing radiation exposure to healthy tissue and improving patient outcomes. QRS is headquartered in Philadelphia and has received support from the National Cancer Institute and the National Science Foundation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quantitative Radiology.